Merus Labs International Inc ($MSL) - buy or sell? Stock discussion, ideas, forum

Merus Labs International Inc

Merus Labs International, Inc.

Industry: Consumer, Non-cyclical

Ticker	Exchange	ISIN
$MSL	TSX	CA59047R1010

Recent news

Kinaxis Inc Net Income dropped on 41.2% while Revenue surged on 17.0%

B2Gold Corp reports 114% Net Income growth in 2020 and 11.0 pp EBITDA Margin growth from 65.6% to 76.6%

Tucows Inc reports 35.8% EBITDA decline in 2020 and 7.7% Revenue decline

KFG Resources Ltd reports 23.7% revenue decline in FY2020 and 25.1 pp EBITDA Margin decline from -3.5% to -28.6%

EXFO Inc EBITDA dropped on 30.3% and Revenue decreased on 7.4%

Arctic Hunter Energy Inc revenue decline accelerated to 47.8% in FY2020 vs. 37.7% a year earliner

Canyon Creek Food Co Ltd reports 38.5% revenue growth in FY2020 and 0.53 pp EBITDA Margin decline from -13.1% to -13.7%

Orbit Garant Drilling Inc Debt surged on 39.8% and Net Debt / EBITDA surged on 1.1x from 3.0x to 4.1x

Rochester Resources Ltd revenue returned to growth in FY2020: increased 13.2% vs. 19.2% decline a year earliner

Quizam Media Corp reports 8.0% revenue decline in FY2020 and 80.7 pp EBITDA Margin growth from -265% to -184%

Twit about MSL stock

Share your investment idea or question on Merus Labs International Inc stock:

Latest twits on Merus Labs International Inc (MSL)

No twits yet. Be the first to post!

Have a question about MSL? Ask and other investors will be eager to help you.

Have an idea about MSL? Share it with other investors.

Merus Labs International Inc stock price chart

Merus Labs International Inc financials

mln. CAD	FY2012	FY2013	FY2014

Revenue	10.421	28.386	26.151
EBITDA	3.433	18.372	12.093
Net income	-20.721	-3.102	-8.062
CAPEX	0.004	0.010	0.125
Debt	54.087	38.066	78.060
Cash	3.463	8.084	14.359

About Merus Labs International Inc

Merus Labs International, Inc. is a specialty pharmaceutical company that acquires established branded pharmaceutical products in Europe and North America.